BRCA1 and neoplasm: HRR deficiency was defined as a biallelic alteration in BRCA1/2, ATM, FANCA, PALB2, CHEK2, BRIP1, or HDAC2, assessed by a blood-based circulating tumor DNA (ctDNA) or tissue-based test.